Decreased interferon-gamma (IFN-γ)-producing T cells in patients with acute Kawasaki disease

Clinical and Experimental Immunology

Volumn 116, Issue 3, 1999, Pages 554-557

  Matsubara, Tomoyo ^a   Katayama, K ^a   Matsuoka, T ^a   Fujiwara, M ^a   Koga, M ^a   Furukawa, S ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Kawasaki disease; Th1 Th2 T cell

Indexed keywords

GAMMA INTERFERON;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; IMMUNOPATHOGENESIS; INFANT; INTERFERON PRODUCTION; LYMPHOCYTE CLONE; MACROPHAGE ACTIVATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VASCULITIS;

ANTIGENS, CD3; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 0032998248     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00899.x     Document Type: Article

References (31)

1. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, Yabuta K, Kato H. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988; 48:247-51.
2. Furukawa S, Matsubara T, Yabuta K. Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child 1992; 67:706-8.
3. Matsubara T, Furukawa S, Yubuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary artery lesions. Clin Immunol Immunopathol 1990; 56:29-36.
4. Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr 1994; 124:721-5.
5. Furukawa S, Imai K, Matsubara T, Yone K, Yachi A, Okumura K, Yabuta K. Increased levels of circulating intercellular adhesion molecule-1 in Kawasaki disease. Arthritis Rheum 1992; 35:672-7.
6. Koga M, Ishihara T, Takahashi M, Umezawa Y, Furukawa S. Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructual and immunohistochemical investigation. Pathol Int 1998; 48:512-7.
7. Sugawara T, Hattori S, Hirose S, Furukawa S, Yabuta K, Shirai T. Immunopathology of the skin lesions of Kawasaki disease. In: Schulman ST, ed. Kawasaki disease. New York: Alan R Liss, 1987:185-92.
8. Terai M, Kohno Y, Namba M, Umemiya T, Niwa K, Nakajima H, Mikata A. Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol 1990; 21:231-4.
9. Leung DYM, Chu ET, Wood N, Grady S, Meade R, Geha RS. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol 1983; 130:2002-4.
10. Barron K, DeCunto C, Montalvo J, Orson F, Lewis D. Abnormalities of immunoregulation in Kawasaki syndrome. J Rheumatol 1988; 15:1243-9.
11. Terai M, Kohno Y, Niwa K, Toba T, Sakurai N, Nakajima H. Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 1987; 60:555-9.
12. Furukawa S, Matsubara T, Tsuji K, Motohashi T, Okumura K, Yabuta K. Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol 1991; 86:134-9.
13. Furukawa S, Matsubara T, Tsuji K, Okumura K, Yahuta K. Transient depletion of T cells with bright CD11a/CD18 expression from peripheral circulation during acute Kawasaki disease. Scand J Immunol 1993; 37:377-80.
14. Furukawa S, Matsubara T, Obara T, Imai K, Okumura K, Yabuta K. Soluble CD2 levels in serum during acute Kawasaki disease and infectious mononucleosis. J Infect Dis 1993; 167:778-9.
15. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DYM, Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 1992; 89:4066-70.
16. Abe J, Kotzin BL, Meissner C et al. Characterization of T-cell repertoire changes in acute Kawasaki disease. J Exp Med 1993; 177:791-6.
17. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki disease. Lancet 1993; 342:1385-8.
18. Pietra BA, De Inocencio J, Giannini EH, Hirsch R. TCRVβ family repertoire and T cell activation markers in Kawasaki disease. J Immunol 1994; 153:1881-8.
19. Terai M, Miwa K, Williams T, Kabat W, Fukuyama M, Okajima Y, Igarashi H, Schulman ST. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 1995; 172:558-61.
20. Choi J-H, Chwae Y-J, Shim W-S, Kim D-S, Kwon D-H, Kim J-D, Kim S-J. Clonal expansion of CD8+ T cells in Kawasaki disease. J Immunol 1997; 159:481-6.
21. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
22. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intercellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197-207.
23. Krung N, Madden J, Redington AE et al. T-cell cylokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 1996; 14:319-26.
24. Kawasaki T, Kosaki G, Osawa S, Shigematsu I, Yanagawa S. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54:271-6.
25. Jung T, Lack G, Schauer U, Uberuck W, Rentz H, Gelfand EW, Rieger CHL. Decreased frequency of interferon-γ- and interleukin-2- producing cells in patients with atopic disease measured at the single cell level. J Allergy Clin Immunol 1995; 96:515-27.
26. Crucian B, Dunne P, Friededman H, Ragsdale R, Pross S, Widen R. Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis. Clin Diagn Lab Immunol 1996; 3:411-6.
27. Qun ZY, Lorre K, de Boer M, Ceuppens JL, B7-blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells. J Immunol 1997; 158:4734-40.
28. Gold KN, Weyand CM, Goronzy JJ. Modulation of helper T cell function by prostaglandins. Arthritis Rheum 1994; 6:925-33.
29. Lee T, Furukawa S, Fukuda Y, Yabuta K, Kato H. Plasma prostaglandin E2 levels in Kawasaki disease. Prostaglandins Leukot Essent Fatty Acids 1988; 31:53-57.
30. Hirao J, Hibi S, Andoh T, Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 1996; 112:152-6.
31. Matsubara T, Fujita Y, Sato T, Sasai K, Furukawa S. The prevalence of allergy in Kawasaki disease. Allergy 1998; 53:815-6.